Literature DB >> 13898102

Activation phenomenon of Clostridium botulinum type E toxin.

J GERWING, C E DOLMAN, D A ARNOTT.   

Abstract

Gerwing, Julia (The University of British Columbia, Vancouver, Canada), Claude E. Dolman, and David A. Arnott. Activation phenomenon of Clostridium botulinum type E toxin. J. Bacteriol. 84:302-306. 1962-Highly purified preparations of both nonactivated and trypsin-activated type E botulinus toxins have been analyzed in an ultracentrifuge. Untreated botulinus type E toxin was found to have a sedimentation constant (S(20,w)) of 5.6 Svedberg units, whereas trypsin-activated toxins would not form a boundary under identical conditions. These and other considerations indicate that the mechanism of tryptic activation involves a fragmentation process whereby more toxic sites become exposed.

Entities:  

Keywords:  CLOSTRIDIUM BOTULINUM; TOXINS AND ANTITOXINS

Mesh:

Substances:

Year:  1962        PMID: 13898102      PMCID: PMC277861          DOI: 10.1128/jb.84.2.302-306.1962

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  9 in total

1.  Studies on toxin production of Clostridium botulinum type E. III. Characterization of toxin precursor.

Authors:  G SAKAGUCHI; S SAKAGUCHI
Journal:  J Bacteriol       Date:  1959-07       Impact factor: 3.490

2.  Purification and activation of Clostridium botulinum type E toxin.

Authors:  J GERWING; C E DOLMAN; D A ARNOTT
Journal:  J Bacteriol       Date:  1961-05       Impact factor: 3.490

3.  Fish eggs as a cause of human botulism. Two outbreaks in British Columbia due to types E and B botulinus toxins.

Authors:  C E DOLMAN; M TOMSICH; C C CAMPBELL; W B LAING
Journal:  J Infect Dis       Date:  1960 Jan-Feb       Impact factor: 5.226

4.  Physiology of toxin production by Clostridium botulinum types A and B. IV. Activation of the toxin.

Authors:  P F BONVENTRE; L L KEMPE
Journal:  J Bacteriol       Date:  1960-01       Impact factor: 3.490

5.  Recent observations on type E botulism.

Authors:  C E DOLMAN
Journal:  Can J Public Health       Date:  1957-05

6.  Activation of Clostridium botulinum type E toxin by trypsin.

Authors:  J T DUFF; G G WRIGHT; A YARINSKY
Journal:  J Bacteriol       Date:  1956-10       Impact factor: 3.490

7.  Studies on the toxin production of Clostridium botulinum type E. II. The mode of action of the contaminant organisms to promote toxin production of type E organisms.

Authors:  G SAKAGUCHI; Y TOHYAMA
Journal:  Jpn J Med Sci Biol       Date:  1955-06

8.  Studies on immunity to toxins of Clostridium botulinum. VII. Purification and detoxification of trypsin-activated type E toxin.

Authors:  M A FIOCK; A YARINSKY; J T DUFF
Journal:  J Bacteriol       Date:  1961-07       Impact factor: 3.490

9.  Studies on the toxin production of Clostridium botulinum type E. I. A strain of genus Clostridium having the action to promote type E botulinal toxin production in a mixed culture.

Authors:  G SAKAGUCHI; Y TOHYAMA
Journal:  Jpn J Med Sci Biol       Date:  1955-06
  9 in total
  5 in total

1.  Kinetics of the thermal inactivation of type E Clostridium botulinum toxin.

Authors:  J J Licciardello; C A Ribich; J T Nickerson; S A Goldblith
Journal:  Appl Microbiol       Date:  1967-03

2.  Effect of nutrients on physiological properties of Clostridium botulinum type E.

Authors:  B Gullmar; N Molin
Journal:  J Bacteriol       Date:  1967-12       Impact factor: 3.490

3.  COMPARATIVE GEL FILTRATION OF TOXIN PRECURSOR AND TRYPSIN-ACTIVATED TOXIN OF CLOSTRIDIUM BOTULINUM TYPE E.

Authors:  G SAKAGUCHI; S SAKAGUCHI; N IMAI
Journal:  J Bacteriol       Date:  1964-02       Impact factor: 3.490

4.  MECHANISM OF TRYPTIC ACTIVATION OF CLOSTRIDIUM BOTULINUM TYPE E TOXIN.

Authors:  J GERWING; C E DOLMAN; A KO
Journal:  J Bacteriol       Date:  1965-05       Impact factor: 3.490

5.  PURIFICATION AND MOLECULAR WEIGHT DETERMINATION OF CLOSTRIDIUM BOTULINUM TYPE E TOXIN.

Authors:  J GERWING; C E DOLMAN; M E REICHMANN; H S BAINS
Journal:  J Bacteriol       Date:  1964-07       Impact factor: 3.490

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.